Materna Medical, Inc., a leading innovator in women’s pelvic health solutions, today announced the establishment of a new ICD ...

Whole-person care has become a “practical necessity,” yet payment models reflect an era “built around episodic visits, ...

Known as "the silent killer" due to its lack of symptoms and reliable screening tests, ovarian cancer remains one of the ...

A man from Gwent has been awarded an MBE in recognition of his outstanding work raising awareness of defibrillators.

Explains the core customs and foreign exchange compliance obligations for exporters operating from the North Eastern Region and why strict adherence is ...

The U.S. FDA has approved narsoplimab (Yartemlea) as the first indicated therapy for hematopoietic stem cell ...

TIRUCHY: The district administration is exploring land pooling schemes to advance the long-pending proposal for a dry port, ...

CHICAGO - Known as 'the silent killer' due to its lack of symptoms and reliable screening tests, ovarian cancer remains one ...

Kenya Revenue Authority plans auction of 16 containers of Brazilian sugar and other goods from February 9-13, 2026, due to ...

Omeros’ Yartemlea gets US FDA approval to treat hematopoietic stem cell transplant-associated thrombotic microangiopathy: Seattle Monday, December 29, 2025, 12:00 Hrs [IST] Omer ...

Eli Lilly boasts a wide range of products that serve a vast number of therapeutic areas. LLY focuses primarily on ...

Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...